Modulation of CYP3A4 activity and induction of apoptosis, necrosis and senescence by the anti-tumour imidazoacridinone C-1311 in human hepatoma cells
Author:
Affiliation:
1. Chemical Faculty; Department of Pharmaceutical Technology and Biochemistry; Gdańsk University of Technology; Narutowicza Str. 11/12, 80-233 Gdańsk Poland
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbin.10018/fullpdf
Reference38 articles.
1. Induction of G2/M arrest and apoptosis of human leukemia cells by potent triazoloacridinone C-1305;Augustin;Biochem Pharmacol,2006
2. Imidazoacridinones arrest cell-cycle progression in the G2 phase of L1210 cells;Augustin;Cancer Chemother Pharmacol,1996
3. Pharmacological and toxicological aspects of new imidazoacridinone antitumour agents;Berger;Cancer Res,1996
4. Phase II trial of C-1311, a novel inhibitor of topoisomerase II in advanced breast cancer;Capizzi;J Clin Oncol,2008
5. Chromophore modified antineoplastic imidazoacridiones. Synthesis and activity against murine leukemias;Cholody;J Med Chem,1992
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acridine as an Anti-Tumour Agent: A Critical Review;Molecules;2022-12-26
2. FeCl3-Catalyzed Synthesis of 6-Thioxo-hexahydroindeno[1′,2′:4,5]imidazo[1,5-a]pyridin-12(6H)-ones via an Interesting [1,2] Oxygen Shift Pathway;The Journal of Organic Chemistry;2022-07-15
3. Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis;Journal of Cellular and Molecular Medicine;2022-06-14
4. Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review;Pharmacological Research;2021-10
5. Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells;Pharmaceuticals;2021-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3